Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Right shift could boost Swedish for-profit

Less than three weeks ahead of the September 11 elections, Swedish parties are neck-to-neck in the opinion polls. The question is whether the centre left Social Democratic Party will remain in power. In its favour is the relative popularity of Prime Minister Magdalena Andersson, who in the polls is well ahead of opposition leaders.

Ramsay rejects new KKR bid after poor results

The acquisition of multinational Australian hospital giant Ramsay Health Care by a consortium led by US PE firm KKR looks likely to fall through, as KKR lowered its offer almost immediately after Ramsay reported disappointing FY2022 results and Ramsay then rejected the new offer.

€1bn for ventilator patient business

Opseo, a German company whose core business is keeping patients alive on mechanical ventilators, is to be sold this autumn. Other players in this uniquely German sector may follow.

German labs sector ‘to grow strongly’

Opportunities for consolidation in the German diagnostic labs sector have almost dried up, according to a large lab operator. But the market as a whole will continue to grow strongly post-Covid, with revenue up as much as 4-5% per annum, he said.

What does Kiwi deal tell us about Bupa’s plans?

Bupa appears to be selling off its New Zealand nursing home arm. What does this mean for the rest of its huge health care services portfolio – which generated revenue of £3.74bn in 2021 – and of its long-term strategy?

KKR exits Max Healthcare

US private equity player KKR has solid its entire stake in India-based hospital chain Max Healthcare, marking its exit from the group, for around Rs9,200 crore. The deal marks its largest exit from an Indian firm, and is the largest single block deal done by any PE firm in India.

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.

KKR may switch to private credit to finance IVI RMA takeover

Facing an increasingly volatile market, American buyout / investment firm KKR may switch to direct lenders to finance its acquisition of fertility company IVI RMA Global, despite agreeing €800m of underwritten financing from four investment banks.

Four Seasons seller happy to split group for sale

Potential buyers of Four Seasons Health Care Group’s (FSHC) 110 homes must place their bids before the end of September, insists Christie & Co, the business broker in charge of the sale.

Find Us